Empagliflozin for Depression: Effective Adjunct with SSRIs (2024 Clinical Trial)
Major Depressive Disorder (MDD) impacts millions globally, making it a significant public health challenge. Traditional treatments like Selective Serotonin Reuptake Inhibitors (SSRIs) don’t …
Read article